English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
According to the latest report by Reports and Data, the global Conventional Syringes market size was valued at USD 12.22 billion in 2022 and is projected to register a revenue CAGR of 7.6% over the forecast period. Conventional Syringes are medical devices used to deliver medications, vaccines, and other therapeutic substances to patients.
The rising prevalence of chronic diseases such as diabetes and cancer, which require injectable medications, is driving the growth of the Conventional Syringes market. Additionally, the demand for reliable and secure medicine delivery systems is also fueling market growth.
Get a free sample PDF of the report, visit @
https://www.reportsanddata.com/download-free-sample/6079
Technical advancements in syringe design and manufacturing have led to the creation of more dependable and secure Conventional Syringes. The adoption of auto-disable Conventional Syringes to stop the spread of infectious diseases is also driving syringe usage. WHO recommends the use of auto-disable Conventional Syringes in vaccination programs, particularly in countries where syringe reuse is common.
In 2022, the conventional Conventional Syringes segment held the largest revenue share in the overall Conventional Syringes market. This is due to the increasing frequency of chronic illnesses such as diabetes and cancer and the need for vaccination programs. The therapeutic injections segment had the largest revenue share in the global Conventional Syringes market in 2022, driven by the rising trend of self-administration of injectable medications and the aging population.
The Asia Pacific region dominated the global Conventional Syringes market's revenue in 2022 due to the senior population and the rising prevalence of chronic illnesses, including diabetes, cancer, and cardiovascular disorders. The global Conventional Syringes market includes several prominent players, including Becton, Dickinson and Company, Gerresheimer AG, Schott AG, West Pharmaceutical Services, Inc., Nipro Corporation, TERUMO CORPORATION, Medtronic, B. Braun Melsungen AG, Smiths Medical, Inc., and Cardinal Health, Inc.
To know more about the latest insights of the report, visit @
https://www.reportsanddata.com/request-latest-insight/6079
Medtronic released its MiniMed 780G advanced hybrid closed-loop insulin delivery system in the European market on 7 March 2022. This system offers personalized glucose management and can automatically adjust insulin delivery to reduce high and low glucose levels.
On 13 September 2022, Becton and Dickinson Company (BD) launched the BD Neopak syringe, designed for administering intravenous (IV) medications. This syringe has a low residual volume, which reduces drug waste and minimizes the risk of medication errors.
The global Conventional Syringes market has been segmented by Reports and Data based on Product Type Outlook, Application Outlook, and Regional Outlook. The product type outlook includes conventional Conventional Syringes, safety Syringes, pre-filled Syringes, and others.
The application outlook includes immunization injections, therapeutic injections, and blood specimen collection. The regional outlook includes North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Notable Innovations In the Conventional Syringes Market –
The Conventional Syringes market has seen notable innovations in recent years, with advancements in syringe design and manufacturing leading to the creation of more reliable and secure Conventional Syringes. Here are some notable innovations in the Conventional Syringes market:
- Auto-disable Conventional Syringes: These Conventional Syringes are designed to prevent reuse, reducing the spread of infectious diseases. The World Health Organization (WHO) recommends the use of auto-disable Conventional Syringes for vaccination programs, particularly in countries where syringe reuse is common. The use of auto-disable Conventional Syringes is increasing as the importance of halting the transmission of infectious diseases grows.
- Pre-filled Conventional Syringes: These Conventional Syringes come pre-filled with medications, making it easier and more convenient for patients to administer their own medication at home. Pre-filled Conventional Syringes also reduce the risk of dosage errors and contamination during medication preparation.
- Safety Conventional Syringes: These Conventional Syringes have built-in safety features that prevent needlestick injuries and the spread of bloodborne diseases. Safety Conventional Syringes are particularly useful in healthcare settings where there is a risk of accidental needlestick injuries, such as hospitals and clinics.
- Smart Conventional Syringes: These Conventional Syringes have electronic components that enable automatic tracking of medication administration, dosage, and patient compliance. Smart Conventional Syringes can help healthcare providers monitor patients more effectively and improve medication adherence.
- Hybrid closed-loop insulin delivery systems: These advanced systems are used for the treatment of diabetes and consist of a smart insulin pump and a continuous glucose monitor. The system automatically adjusts insulin delivery based on the patient's glucose levels, reducing the risk of high and low glucose levels and improving patient outcomes.
Request a customized copy of the report @
https://www.reportsanddata.com/request-customization-form/6079
Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Browse for more reports…
